brivanib alaninate
Cancer
(brih-VAN-ib a-luh-NIN-ayt) A substance being studied in the treatment of cancer. Brivanib alaninate blocks the growth of new blood vessels needed for tumors to grow and may kill cancer cells. It is a type of vascular endothelial growth factor receptor 2 inhibitor and a type of antiangiogenesis agent.